Abstract
In our previous study, we had identified SOX30 as a novel tumor suppressor that acts through direct regulation of p53 transcription in human lung cancer. Here, we sought to determine the clinical relevance of SOX30 expression in a series of surgically-resected non-small cell lung cancer (NSCLC) patients. Analysis of SOX30 expression and clinico-pathologic features reveal a significant correlation of SOX30 expression with histological type (n = 220, P = 0.008) and clinical stage (n = 220, P = 0.024). Kaplan-Meier analysis indicates an association of high SOX30 expression with better prognosis in NSCLC patients (n = 220, P = 0.007). Via multivariate Cox-regression analysis, SOX30 expression is revealed to be an independent prognostic factor for overall survival (OS) of NSCLC patients (n = 220, P = 0.014, hazard ratio (HR) = 0.816). In particular, SOX30 is a favorable and independent prognostic factor in one main subtype of NSCLC, lung adenocarcinoma (ADC) patients (n = 150, P = 0.000, HR = 0.405), but not in another main subtype of NSCLC, squamous cell carcinoma patients. Furthermore, high expression of SOX30 represents a favorable and independent factor for the prognosis of ADC patients at clinical stage II (P = 0.013), with pos...Continue Reading
References
Dec 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D F Hayes
Dec 1, 1995·Journal of Clinical Epidemiology·P PeduzziT R Holford
Jun 9, 1999·Nucleic Acids Research·E OsakiK Semba
Mar 16, 2002·Neoplasia : an International Journal for Oncology Research·Amy L McDoniels-SilversMing You
Jun 25, 2002·The Annals of Thoracic Surgery·Joseph Watine
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Mar 28, 2006·Developmental Biology·D BallowA Rajkovic
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qiang GaoZhao-You Tang
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
Sep 26, 2008·The New England Journal of Medicine·Roy S HerbstScott M Lippman
Apr 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gloria S HuangSusan Band Horwitz
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Dec 15, 2010·BMC Molecular Biology·Fei HanDeshou Wang
Feb 1, 2011·The Lancet Oncology·William Pao, Nicolas Girard
Mar 13, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Pablo Perez-MorenoJean-Charles Soria
May 24, 2012·Expert Review of Molecular Diagnostics·William C S Cho
Oct 16, 2012·Molecular Biology Reports·Li-Nian HuangFeng-Dan Hu
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 18, 2014·Seminars in Interventional Radiology·Carole A RidgeMichelle S Ginsberg
May 9, 2014·PloS One·Fei HanJinyi Liu
Aug 19, 2014·Scientific Reports·Liang PengShun-Chang Jiao
Dec 2, 2014·Oncogene·F HanJ Liu
Dec 4, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Seung Hyeun LeeKwang Ho In
Dec 5, 2014·Future Oncology·Xiao QuJiajun Du
Citations
May 16, 2017·Oncogenesis·S T GuoC C Jiang
Mar 31, 2017·Molecular Cancer·Yan DongJian-Jun Li
Dec 1, 2017·Journal of Experimental & Clinical Cancer Research : CR·Juntang YangJinyi Liu
Aug 3, 2017·Future Oncology·Yan DongDeng-Ke Yang
Jan 5, 2019·Endocrine-related Cancer·Fei HanJin-Yi Liu
Mar 12, 2020·Journal of Clinical Laboratory Analysis·Hui PengWanling Yin
Oct 27, 2017·Oncotarget·Jian XiaoQiong Chen
Jun 2, 2018·Journal of Experimental & Clinical Cancer Research : CR·Xianglin HaoJinyi Liu
Dec 6, 2018·Respiratory Research·Fei HanJin-Yi Liu
Jan 1, 2020·Cellular & Molecular Biology Letters·Qiang FuHe Wang
Jul 14, 2018·Clinical Epigenetics·Jing-Dong ZhouJun Qian
May 31, 2019·Cell Death & Disease·Xiang-Lin HaoJin-Yi Liu
Jun 9, 2018·BMC Cancer·Yang LiuAifa Tang
Jul 3, 2021·Cancers·Anna Klimaszewska-WiśniewskaMaciej Gagat